Fifty Hertz electromagnetic field exposure stimulates secretion of β-amyloid peptide in cultured human neuroglioma

Neuroscience Letters

Volumn 418, Issue 1, 2007, Pages 9-12

  Del Giudice, Elda ^a   Facchinetti, Fabrizio ^a   Nofrate, Valentina ^a,b   Boccaccio, Pasquale ^c   Minelli, Tullio ^b   Dam, Mauro ^d   Leon, Alberta ^a,d   Moschini, Giuliano ^b,c  

^a Research and Innovation R and I Company   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SEZIONE DI PADOVA   (Italy)

^d IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloidogenesis; Electromagnetic fields; Neuron; Occupational risk

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; EXPOSURE; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN SECRETION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; ELECTROMAGNETIC FIELDS; GLIOMA; HUMANS; OCCUPATIONAL EXPOSURE; RADIATION;

EID: 34247099691     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.02.057     Document Type: Article

References (26)

1. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., and Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17 (1996) 1005-1013
2. Buxbaum J.D., Ruefli A.A., Parker C.A., Cypess A.M., and Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4489-4493
3. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslop P., and Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3 (1997) 67-72
4. Coulton L.A., Harris P.A., Barker A.T., and Pockley A.G. Effect of 50 Hz electromagnetic fields on the induction of heat-shock protein gene expression in human leukocytes. Radiat. Res. 161 (2004) 430-434
5. Feychting M., Pedersen N.L., Svedberg P., Floderus B., and Gatz M. Dementia and occupational exposure to magnetic fields. Scand J. Work Environ. Health 24 (1998) 46-53
6. Feychting M., Jonsson F., Pedersen N.L., and Ahlbom A. Occupational magnetic field exposure and neurodegenerative disease. Epidemiology 14 (2003) 413-419
7. Gartzke J., and Lange K. Cellular target of weak magnetic fields: ionic conduction along actin filaments of microvilli. Am. J. Physiol. Cell Physiol. 283 (2002) C1333-C1346
8. Graves A.B., Rosner D., Echeverria D., Yost M., and Larson E.B. Occupational exposure to electromagnetic fields and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 13 (1999) 165-170
9. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., and Selkoe D.J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
10. Harmanci H., Emre M., Gurvit H., Bilgic B., Hanagasi H., Gurol E., Sahin H., and Tinaz S. Risk of neurodegenerative diseases in welders and other workers exposed to high levels of magnetic fields. Epidemiology 14 (2003) 420-428
11. Haugabook S.J., Yager D.M., Eckman E.A., Golde T.E., Younkin S.G., and Eckman C.B. High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid beta peptide (Abeta). J. Neurosci. Methods 108 (2001) 171-179
12. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., Younkin S.G., and Borchelt D.R. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42 specific gamma Secretase. Hum. Mol. Genet. 13 (2004) 159-170
13. Johansen C. Exposure to electromagnetic fields and risk of central nervous system disease in utility workers. Epidemiology 11 (2000) 539-543
14. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosi. 3 (2002) 862-872
15. Mattson M.P., and Chan S.L. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J. Mol. Neurosci. 17 (2001) 205-224
16. Noonan C.W., Reif J.S., Yost M., and Touchstone J. Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. Scand J. Work Environ. Health 28 (2002) 42-48
17. Phillips J.L. Effects of electromagnetic field exposure on gene transcription. J. Cell Biochem. 51 (1993) 381-386
18. Qiu C., Fratiglioni L., Karp A., Winblad B., and Bellander T. Occupational exposure to electromagnetic fields and risk of Alzheimer's disease. Epidemiology 15 (2004) 687-694
19. Rao R.R., Halper J., and Kisaalita W. Effects of 60 Hz electromagnetic field exposure on APP695 transcription levels in differentiating human neuroblastoma cells. Bioelectrochemistry 57 (2002) 9-15
20. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schiossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359 (1992) 325-327
21. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., and Younkin S.G. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258 (1992) 126-129
22. Sobel E., Davanipour Z., and Sulkava R. Occupations with exposure to electromagnetic fields: a possible risk factor for Alzheimer's disease. Am. J. Epidemiol. 142 (1995) 515-524
23. Sobel E., and Davanipour Z. Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer's disease. Neurology 47 (1996) 1594-1600
24. Sobel E., Dunn M., and Davanipour Z. Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology 47 (1996) 1477-1481
25. Tomita T., Maruyama K., Saido T.C., Kume H., Shinozaki K., Tokuhiro S., Capell, Walter J., Grunberg J., Haass C., Iwatsubo T., and Obata K. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2025-2030
26. Wang R., Sweeney D., Gandy S.E., and Sisodia S.S. The profile of solubile amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271 (1996) 31894-31902